Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Journal of Stomatology ; (12): 180-183, 2007.
Article in Chinese | WPRIM | ID: wpr-333373

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the inhibition of telomerase activity and cellular proliferation in tongue cancer TCCA-8113 cell lines by antisense human tankyrase-1 RNA treatment, and explore the possibility of the tankyrase-1 as a target of gene therapy for tongue cancer.</p><p><b>METHODS</b>The replication deficient retrovirus expressing tankyrase-1 antisense RNA was constructed to infect the TCCA-8113 cells. Tankyrase-1 expression was examined by RT-PCR. Telomerase activity was assayed by telomerase repeat amplification protocol (TRAP). Cell proliferation was investigated by cellular growth curve. Cellular apoptosis was detected by flow cytometry method and invert microscope.</p><p><b>RESULTS</b>Tankyrase-1 expression and telomerase activity of tongue cancer TCCA-8113 cells were significantly inhibited. There was G(1)-S phase arrest when TCCA-8113 cells were treated with antisense tankyrase-1 transduction. Cellular proliferation was arrested, and cellular apoptosis occurred after antisense tankyrase transduction.</p><p><b>CONCLUSIONS</b>The transduction of antisense tankyrase-1 by retroviral vector can significantly inhibit the tankyrase-1 expression and telomerase activity of tongue cancer TCCA-8113 cell lines, and arrest the cellular proliferation and promote cellular apoptosis. The tankyrase may be a potential target of gene therapy for tongue cancer.</p>


Subject(s)
Humans , Apoptosis , Cell Line, Tumor , Cell Proliferation , Genetic Therapy , Genetic Vectors , Genetics , RNA, Antisense , Genetics , Retroviridae , Genetics , Tankyrases , Genetics , Telomerase , Metabolism , Tongue Neoplasms , Genetics , Metabolism , Pathology , Therapeutics , Transfection
2.
Chinese Journal of Otorhinolaryngology Head and Neck Surgery ; (12): 571-574, 2005.
Article in Chinese | WPRIM | ID: wpr-325321

ABSTRACT

<p><b>OBJECTIVE</b>Survivin highly overexpresses in the most of human tumors, and it may play an important role in the development of tumor. The aim of this study was to explore the effects of survivin antisense oligonucleotide (ASODN) on the proliferation and the apoptosis of human Hep-2 cell.</p><p><b>METHODS</b>Hep-2 cells were transfected with survivin ASODN mediated by lipofectamine, MTT [3-(4,5-dimethylthiazol-2-yl)-2, 5 diphenyl tetrazolium bromide] method was used to observe the cell growth inhibitory rate, the expressions of survivin mRNA and protein were detected by reverse transcriptase polymerase chain reaction (RT-PCR) and Western blot respectively. Flow cytometry was used to examine cell apoptosis rate. Kinase activity test was used to detect the changes of caspase-3 activity.</p><p><b>RESULTS</b>Survivin ASODN obviously inhibited the cell growth of Hep-2 cells after transfection. After transfected with survivin ASODN the expressions of survivin mRNA and protein of Hep-2 cells were down-regulated, and apoptosis rate was significantly increased. The activity of caspase-3 increased highly in Hep-2 cells transfected with survivin ASODN, which showed time-dependent.</p><p><b>CONCLUSIONS</b>Survivin ASODN could inhibit the proliferation of Hep-2 cell and induced apoptosis through down-regulating the the expressions of survivin mRNA and protein.</p>


Subject(s)
Humans , Apoptosis , Apoptosis Regulatory Proteins , Pharmacology , Caspase 3 , Metabolism , Cell Proliferation , Hep G2 Cells , Inhibitor of Apoptosis Proteins , Microtubule-Associated Proteins , Genetics , Pharmacology , Oligonucleotides, Antisense , Pharmacology , RNA, Messenger , Genetics
SELECTION OF CITATIONS
SEARCH DETAIL